Vaxil Bio Ltd V.VXL

Alternate Symbol(s): VXLLF

Healthcare Biotechnology

Vaxil Bio Ltd. is a Canada-based biotechnology company. The Company is focused on a drug discovery and development platform based on Signal Peptides (SPs) which the Company deploys to fight infectious diseases and cancer. The Company’s most advanced product, ImMucin, a MUC1 SP-derived vaccine, completed a Phase I/II clinical trial in multiple myeloma. The Company also has a SP-based COVID-19 vaccine candidate and a SP-based tuberculosis vaccine / treatment candidate. In addition, The Company has mAb candidates for the treatment of oncology and infectious diseases to be used alone, and in combination with other treatments. It has also initiated a pre-clinical program for a drug delivery polymer that targets high affinity E-selectin (P-Esbp), which the Company licensed for development and commercialization from BGN Technologies. It exploits the properties of SP domains on crucial proteins to develop targeted therapies against cancer targets and infectious disease pathogens.

TSXV:VXL - Post by User

Vaxil Bio Ltd

<< Previous

Bullboard Posts

Next >>

Post by saintpeteron Apr 23, 2021 8:02pm

105 Views

Post# 33060282

todays trades

House Positions for C:VXL from 20210423 to 20210423

House	Bought	$Val	Ave	Sold	$Val	Ave	Net	$Net
80 National Bank	108,462	13,146	0.121	39,928	4,922	0.123	68,534	-8,224
2 RBC	88,000	10,725	0.122	23,540	2,892	0.123	64,460	-7,833
53 Morgan Stanley	6,000	720	0.12	0			6,000	-720
7 TD Sec	7,410	893	0.121	2,922	355	0.121	4,488	-538
68 Leede	451	54	0.12	37	4	0.108	414	-50
19 Desjardins	50,500	6,100	0.121	50,500	6,100	0.121	0	0
124 Questrade	0			500	60	0.12	-500	60
89 Raymond James	0			3,000	360	0.12	-3,000	360
85 Scotia	34,564	4,195	0.121	52,000	6,240	0.12	-17,436	2,045
33 Canaccord	0			18,500	2,312	0.125	-18,500	2,312
1 Anonymous	4,040	485	0.12	47,500	5,752	0.121	-43,460	5,267
79 CIBC	0			61,000	7,320	0.12	-61,000	7,320
TOTAL	299,427	36,318	0.121	299,427	36,317	0.121	0	-1